Anti-inflammatory effect of α,β-amyrin, a triterpene from Protium heptaphyllum, on cerulein-induced acute pancreatitis in mice

Inflamm Res. 2011 Jul;60(7):673-81. doi: 10.1007/s00011-011-0321-x. Epub 2011 Mar 12.

Abstract

Objective: To evaluate the anti-inflammatory effect of α,β-amyrin, a pentacyclic triterpenoid from Protium heptaphyllum, on cerulein-induced acute pancreatitis in mice.

Methods: Acute pancreatitis was induced in Swiss mice by five intraperitoneal injections of cerulein (50 μg/kg), at 1 h intervals. Mice received α,β-amyrin (10, 30 and 100 mg/kg), thalidomide (200 mg/kg), or vehicle (3% Tween 80) orally 1 h before and 12 h after the cerulein challenge. The severity of pancreatitis was evaluated 24 h after cerulein by assessing serum pro-inflammatory cytokines and amylase activity, pancreatic myeloperoxidase (MPO), and thiobarbituric acid-reactive substances (TBARS), as well as by histology.

Results: α,β-Amyrin and thalidomide significantly attenuated the cerulein-induced increase in tumor necrosis factor (TNF)-α, interleukin-6, lipase, amylase, MPO, and TBARS. Moreover, α,β-amyrin greatly suppressed the pancreatic edema, inflammatory cell infiltration, acinar cell necrosis, and expressions of TNFα and inducible nitric oxide synthase.

Conclusions: α,β-Amyrin ameliorates cerulein-induced acute pancreatitis by acting as an anti-inflammatory and antioxidant agent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amylases / blood
  • Animals
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / therapeutic use*
  • Burseraceae / chemistry*
  • Ceruletide / adverse effects*
  • Disease Models, Animal
  • Immunosuppressive Agents / therapeutic use
  • Interleukin-6 / blood
  • Male
  • Mice
  • Nitric Oxide Synthase Type II / metabolism
  • Oleanolic Acid / analogs & derivatives*
  • Oleanolic Acid / chemistry
  • Oleanolic Acid / therapeutic use
  • Pancreatitis / chemically induced*
  • Pancreatitis / drug therapy*
  • Pancreatitis / pathology
  • Peroxidase / metabolism
  • Random Allocation
  • Thalidomide / therapeutic use
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Anti-Inflammatory Agents
  • Immunosuppressive Agents
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Thalidomide
  • Oleanolic Acid
  • Ceruletide
  • Peroxidase
  • Nitric Oxide Synthase Type II
  • Amylases
  • beta-amyrin